Showing results (1511-1520 of 2,361) with videos related to

Sort By:
Pageof 237
Clinical Neuropharmacology|November 26, 2009
Estimation of plasma IC50 of donepezil for cerebral acetylcholinesterase inhibition in patients with Alzheimer disease using positron emission tomographyTsuneyoshi Ota, Hitoshi Shinotoh, Kiyoshi Fukushi, et al.
Clinical Neuropharmacology|November 26, 2009
Clinical experiences with levodopa methylester (melevodopa) in patients with Parkinson disease experiencing motor fluctuations: an open-label observational studyRoberta Zangaglia, Fabrizio Stocchi, Massimo Sciarretta, et al.
Clinical Neuropharmacology|November 26, 2009
Successful treatment by paroxetine of delusional disorder, somatic type, accompanied by severe secondary depressionHiroshi Hayashi, Takaki Akahane, Haruyoshi Suzuki, et al.
Clinical Neuropharmacology|November 26, 2009
Early addition of selegiline to L-Dopa treatment is beneficial for patients with Parkinson diseaseYoshikuni Mizuno, Tomoyoshi Kondo, Sadako Kuno, et al.
Clinical Neuropharmacology|July 7, 2017
Can High-Dose Levetiracetam Be Safe? A Case Report of Prolonged Accidental High-Dose Levetiracetam Administration and Review of the LiteratureAyse Kartal
Clinical Neuropharmacology|December 1, 1987
Coexistent tardive dyskinesia and parkinsonismJ Jankovic, J Casabona
Clinical Neuropharmacology|May 17, 2022
What Is the Medication Iatrogenic Risk in Elderly Outpatients for Chronic Pain?Julie Jambon, Chloé Choukroun, Clarisse Roux-Marson, et al.
Clinical Neuropharmacology|January 1, 1988
Obesity, genetics, and ponderal set pointT B Van Itallie
Clinical Neuropharmacology|January 1, 1988
Permanent administration of d-fenfluramine in rats: paradoxical effectsR Rozen, F Fumeron, D Betoulle, et al.
Clinical Neuropharmacology|January 1, 1988
A controlled trial of d-fenfluramine in bulimia nervosaG F Russell, S A Checkley, J Feldman, et al.
Pageof 237